Radiopharma Trials in Latin America: Designing Operations for 6-Hour Half-Lives

Primary keyword: radiopharmaceutical clinical trial logistics Latin America

Radiopharmaceuticals are one of the most promising frontiers in oncology, but they force clinical teams to operate on a different clock. An industry announcement noted that because these materials decay in hours rather than months, the operational window for patient administration is extremely narrow, leaving very little margin for error.

Latin America can be an attractive region for radiopharma development, but sponsors need an operating model that is designed for short half-lives, just-in-time supply, and site readiness. This article outlines a practical framework for radiopharmaceutical clinical trial logistics in Latin America—without duplicating country-specific checklists already covered elsewhere.

1) Start with the “decay clock” and design backward

Radiopharma operations should start with physics. If a product’s usable window is measured in hours, then every downstream step must be planned backwards from the scheduled administration time:

• Manufacturing slot and release testing (including potential rework)
• Packaging and validated temperature control
• Transportation and customs risk (for cross-border moves)
• Site receipt, verification, and patient preparation

Operational principle: Do not treat shipment as a “logistics problem.” Treat it as part of the dosing procedure.

2) Build site readiness around minute-by-minute workflows

In many conventional trials, small workflow inefficiencies are tolerated. In radiopharma, they can cause missed windows or protocol deviations.

• Define a standard receiving workflow: who signs, where it is stored, and how identity and activity are verified.
• Train for exceptions: delayed flights, partial shipments, or last-minute patient rescheduling.
• Synchronize departments: nuclear medicine, pharmacy, imaging, and the clinical team must share one operational plan.

3) Manage supply risk with redundancy and “plan B” lanes

A radiopharma webinar announcement highlighted just-in-time manufacturing and strict cold-chain requirements as differentiators from standard investigational products, and emphasized that protocol pivots and supply disruptions are expected rather than rare. In Latin America, the right mitigation strategies can include:

• Backup transport lanes: pre-qualified couriers and alternate airport routing options.
• Site network design: cluster sites to reduce travel time from production to administration.
• Inventory philosophy: you cannot “stockpile” short half-life product, so redundancy must come from operations, not storage.

4) A practical operating model for Latin America radiopharma programs

To make logistics predictable, sponsors can standardize four elements across countries:

• Readiness checklists: site staffing, equipment calibration, temperature monitoring, and emergency procedures.
• Scheduling discipline: patient scheduling should be tied to confirmed manufacturing slots and transport windows.
• Visibility: live tracking of manufacturing status, shipment milestones, and site receipt confirmation.
• Contingency triggers: pre-defined thresholds for when to reschedule a patient, re-route a shipment, or activate an alternate site.

When these elements are standardized, the operational advantage of Latin America—experienced research sites and growing infrastructure—can translate into reliable execution, not just theoretical speed.

5) Data integrity and chain-of-custody: treat the dose as a specimen

With radiopharmaceuticals, sponsors should document the product journey with the same rigor used for biospecimens. This reduces deviations and supports inspection readiness.

• Time-stamped handoffs: manufacturing release, courier pickup, arrival at site, and administration time.
• Temperature and shielding logs: continuous monitoring, out-of-range triggers, and documented corrective actions.
• Identity checks: verify patient, product label, and activity at the moment of administration.

Practical tip: Create a single-page “dose administration record” that sites can complete in real time and upload the same day.

6) Regulatory and customs planning: design for border reality

Latin America is not one regulatory system. Cross-border moves can introduce unpredictable delays, so logistics planning should assume variability and reduce exposure wherever possible.

• Prefer in-country or near-country production when feasible: shorter transit times reduce decay loss.
• Pre-clear documentation: align on import documentation, labeling, and receiver information well before first shipment.
• Schedule around local constraints: weekends, holidays, and airport cutoffs matter more when the product lifetime is measured in hours.

When sponsors plan for these constraints, Latin America sites can deliver high-quality execution even for time-sensitive protocols.

FAQ: Radiopharmaceutical clinical trial logistics Latin America

• Why are radiopharmaceutical trials harder to run than conventional trials?
  Because many products decay in hours, the operational window is extremely narrow and sites must coordinate manufacturing, shipping, and patient readiness with little margin for error.
• What is the most common operational failure mode?
  Missed administration windows caused by delays in manufacturing release, transportation, site workflow issues, or patient no-shows.
• How can Latin America sites reduce missed dosing windows?
  By building standardized readiness checklists, aligning patient scheduling with shipment timelines, and designing contingency plans for transportation or manufacturing disruptions.

Planning a radiopharma study in Latin America? bioaccess® can help sponsors design site networks, readiness plans, and startup execution models that reduce missed dosing windows.